Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA. | Cell Rep | 2022 | 36417866 | PubTator, text mining | PubMed |
| Interferon partly dictates a divergent transcriptional response in poxvirus-infected and bystander inflammatory monocytes. | Cell Rep | 2022 | 36417857 | PubTator, text mining | PubMed |
| SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells. | Elife | 2022 | 36408799 | PubTator, text mining | PubMed |
| Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation. | Curr Stem Cell Rep | 2022 | 36406259 | PubTator, text mining | PubMed |
| A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients. | Front Immunol | 2022 | 36389738 | PubTator, text mining | PubMed |
| Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. | Cell Rep Med | 2022 | 36384096 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma. | Biomark Res | 2022 | 36376989 | PubTator, text mining | PubMed |
| Host-Directed Therapies for Tuberculosis. | Pathogens | 2022 | 36365041 | PubTator, text mining | PubMed |
| Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma. | J Clin Med | 2022 | 36362802 | PubTator, text mining | PubMed |
| Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes. | Int J Mol Sci | 2022 | 36362253 | PubTator, text mining | PubMed |
| COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. | Int J Mol Sci | 2022 | 36362045 | PubTator, text mining | PubMed |
| Deregulated Expression of Circular RNAs Is Associated with Immune Evasion and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. | Genes (Basel) | 2022 | 36360223 | PubTator, text mining | PubMed |
| The Role of Epigenetics in the Development and Progression of Multiple Myeloma. | Biomedicines | 2022 | 36359286 | PubTator, text mining | PubMed |
| Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies. | Cancers (Basel) | 2022 | 36358861 | PubTator, text mining | PubMed |
| The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy. | Cancers (Basel) | 2022 | 36358715 | PubTator, text mining | PubMed |
| Immune and Genomic Analysis of Boxer Dog Breed and Its Relationship with Leishmania infantum Infection. | Vet Sci | 2022 | 36356085 | PubTator, text mining | PubMed |
| Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non-small-cell lung carcinoma. | iScience | 2022 | 36339256 | PubTator, text mining | PubMed |
| Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis. | Front Oncol | 2022 | 36330486 | PubTator, text mining | PubMed |
| The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O155). | Bone Marrow Transplant | 2022 | 36323939 | PubTator, text mining | PubMed |
| EZH2: Its regulation and roles in immune disturbance of SLE. | Front Pharmacol | 2022 | 36313363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=31